MOUHANAD AL-FAKIH: Open Payments
NPI 1013914605 · CONNELLSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 105 payments from 17 companies in 2025. Trend: 2023 $1,874 · 2024 $2,192 · 2025 $2,409
Food & beverage: $2,297Education: $111
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $627 |
| Novo Nordisk Inc | 17 | $394 |
| Teva Pharmaceuticals USA, Inc. | 10 | $274 |
| GlaxoSmithKline, LLC. | 12 | $231 |
| Otsuka America Pharmaceutical, Inc. | 8 | $149 |
| Aimmune Therapeutics, Inc. | 8 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $113 |
| Lundbeck LLC | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
Products named: AIRSUPRA, BREZTRI, REXULTI, TRELEGY ELLIPTA, AUSTEDO XR, ZENPEP, FARXIGA, Kerendia.
Industry payments across PA — which companies pay providers there.
